HOOKIPA Pharma Inc. Quarterly Interest Expense in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
HOOKIPA Pharma Inc. quarterly/annual Interest Expense history and growth rate from Q1 2018 to Q1 2024.
  • HOOKIPA Pharma Inc. Interest Expense for the quarter ending March 31, 2024 was $2K, a 98.4% decline year-over-year.
  • HOOKIPA Pharma Inc. Interest Expense for the twelve months ending March 31, 2024 was $197K, a 65.2% decline year-over-year.
  • HOOKIPA Pharma Inc. annual Interest Expense for 2023 was $317K, a 53.9% decline from 2022.
  • HOOKIPA Pharma Inc. annual Interest Expense for 2022 was $687K, a 23.5% decline from 2021.
  • HOOKIPA Pharma Inc. annual Interest Expense for 2021 was $898K, a 14.2% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $197K $2K -$120K -98.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $317K $49K -$59K -54.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $376K $49K -$56K -53.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $432K $97K -$134K -58% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $566K $122K -$121K -49.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $687K $108K -$119K -52.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $806K $105K -$129K -55.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $935K $231K +$13K +5.96% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $922K $243K +$24K +11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $898K $227K +$28K +14.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-22
Q3 2021 $870K $234K +$40K +20.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $830K $218K +$52K +31.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $778K $219K -$8K -3.52% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $786K $199K -$28K -12.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $814K $194K -$33K -14.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $847K $166K -$44K -21% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $891K $227K +$14K +6.57% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $877K $227K +$27K +13.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-24
Q3 2019 $850K $227K +$33K +17% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $817K $210K +$19K +9.95% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $798K $213K +$20K +10.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $778K $200K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 $194K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $191K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $193K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.